In prostate cancer, EGR3 suppresses metastasis by inducing the expression of tumor suppressor genes, such as ZFP36 and SOCS3 [18], while additional evidence suggests that EGR3 loss correlates with relapse and reduced survival [25]. Here, EGR3 is linked to prostate carcinoma.